LOGICMARK INC (LGMK)
US67091J5039 - Common Stock
Taking everything into account, LGMK scores 2 out of 10 in our fundamental rating. LGMK was compared to 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of LGMK is average, but there are quite some concerns on its profitability. LGMK has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year LGMK has reported negative net income.
LGMK had a negative operating cash flow in the past year.
In the past 5 years LGMK always reported negative net income.
LGMK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of -115.61%, LGMK is not doing good in the industry: 84.41% of the companies in the same industry are doing better.
LGMK's Return On Equity of -131.35% is on the low side compared to the rest of the industry. LGMK is outperformed by 73.12% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -115.61% | ||
| ROE | -131.35% | ||
| ROIC | N/A |
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 66.93%, LGMK is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
In the last couple of years the Gross Margin of LGMK has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for LGMK so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.93% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%
2. Health
2.1 Basic Checks
LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LGMK has more shares outstanding
Compared to 5 years ago, LGMK has more shares outstanding
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
LGMK has an Altman-Z score of -11.56. This is a bad value and indicates that LGMK is not financially healthy and even has some risk of bankruptcy.
LGMK has a worse Altman-Z score (-11.56) than 82.80% of its industry peers.
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -11.56 |
ROIC/WACCN/A
WACC8.66%
2.3 Liquidity
LGMK has a Current Ratio of 2.78. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
LGMK's Current ratio of 2.78 is in line compared to the rest of the industry. LGMK outperforms 48.39% of its industry peers.
LGMK has a Quick Ratio of 2.36. This indicates that LGMK is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.36, LGMK perfoms like the industry average, outperforming 54.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.78 | ||
| Quick Ratio | 2.36 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 36.14% over the past year.
Looking at the last year, LGMK shows a decrease in Revenue. The Revenue has decreased by -2.94% in the last year.
Measured over the past years, LGMK shows a very negative growth in Revenue. The Revenue has been decreasing by -10.32% on average per year.
EPS 1Y (TTM)36.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.27%
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%0.39%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y67.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.7%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
LGMK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year LGMK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
LGMK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
LOGICMARK INC
NASDAQ:LGMK (10/17/2024, 8:47:32 PM)
After market: 0.0875 +0 (+3.31%)0.0847
0 (-0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap308.31K
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -115.61% | ||
| ROE | -131.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.93% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.78 | ||
| Quick Ratio | 2.36 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)36.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y67.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-4.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y